Journal article
An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine
New vaccine technologies may improve the acceptability, delivery (potentially enabling self-administration), and product efficacy of influenza vaccines. One such technology is the microneedle patch (MNP), a skin delivery technology currently in development. Although MNPs hold promise in preclinical studies, their potential economic and epidemiologic impacts have not yet been evaluated.
Authors
- Angela R. Wateska
- Sarah M. Bartsch
-

Mercy Mvundura
View profile | More articles - Mark R. Prausnitz
- Kristina M. Zapf
- Kathleen Marinan
- James J. Norman
- Erica Jacoby
-

Darin Zehrung
View profile | More articles -

Courtney Jarrahian
View profile | More articles - Bruce Y. Lee
- Bill Snyder
- Savitha Swaminathan
Languages
- English
Publication year
2015
Journal
Vaccine
Volume
33
Issue
37
Type
Journal article
Categories
- Vaccines & delivery devices
Diseases
- Influenza
Tags
- Delivery device